Bruker Corporation (BRKR) Stock Price
BRKRStock
$54.80+43.46%52W
Market Cap$8.35B
P/E—
PEG Ratio1.52
Div yield0.30%
Beta1.26
BRKR Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)27.44%
Price vs S&P 500 (4W)-9.69%
PEG Ratio1.52
VGM Score45.68
Indicated Dividend Yield (Annual)0.30%
BRKR Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $0.38 | $0.49 | +27.49%(+$0.11) | |
| Q1 2026 | $0.23 | $0.31 | +34.81%(+$0.08) | |
| Q4 2025 | $0.65 | $0.59 | -9.76%(-$0.06) | |
| Q3 2025 | $0.32 | $0.45 | +38.75%(+$0.13) | |
| Q2 2025 | $0.42 | $0.32 | -23.39%(-$0.10) |
BRKR Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
3.91
3.90
3.90
3.86
Industry Peers — Lab Analytical Instruments(25)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
BRKRBruker Corporation | D | D | B | 2.4x | 11.6% | 47.7% | -1.5% | $54.80 |
| AAgilent Technologies Inc. | D | C | A | 6.6x | 5.4% | 53.9% | 22.2% | $172.97 |
| WATWaters Corp | F | C | A | 9.4x | 6.0% | 50.9% | 7.1% | $436.95 |
| ILMNIllumina Inc | D | D | A | 8.8x | 6.0% | 66.4% | 19.5% | $262.54 |
| MTDMettler-Toledo International | D | C | A | 7.9x | 5.5% | 60.3% | 26.6% | $1622.29 |
| RVTYRevvity, Inc. | D | D | A | 5.8x | -5.5% | 55.0% | 12.3% | $152.64 |
| AVTRAvantor, Inc. | C | F | A | 1.7x | 0.5% | 31.8% | -4.7% | $16.42 |
| BIO.BBio-Rad Laboratories, Inc. Class B | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $364.15 |
| BIOBio-Rad Laboratories, Inc.Class A | C | D | B | 3.7x | 0.3% | 51.9% | 1.8% | $353.70 |
| TXG10x Genomics, Inc. Class A Common Stock | F | D | A | 14.8x | 16.6% | 69.6% | -14.3% | $69.86 |
| ALMRAlamar Biosciences, Inc. Common Stock | — | A | B | — | — | — | — | $25.28 |
About Bruker Corporation
Bruker Corporation manufactures scientific instruments and diagnostic tests serving the life sciences, pharmaceutical, and biotechnology industries. The company operates through multiple segments, including BioSpin, CALID, and Nano divisions, with CALID generating the largest revenue contribution. The majority of its revenue is derived from the United States market.